Compare INFU & NARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INFU | NARA |
|---|---|---|
| Founded | 2005 | 2026 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 277.6M | 230.0M |
| IPO Year | 2005 | 2026 |
| Metric | INFU | NARA |
|---|---|---|
| Price | $14.18 | $10.15 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $18.50 | N/A |
| AVG Volume (30 Days) | ★ 136.9K | 125.5K |
| Earning Date | 11-05-2026 | 06-11-2027 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 181.82 | N/A |
| EPS | ★ 0.35 | N/A |
| Revenue | ★ $143,436,000.00 | N/A |
| Revenue This Year | $1.42 | N/A |
| Revenue Next Year | $5.89 | N/A |
| P/E Ratio | $41.63 | ★ N/A |
| Revenue Growth | ★ 6.36 | N/A |
| 52 Week Low | $7.29 | $10.34 |
| 52 Week High | $15.47 | $10.89 |
| Indicator | INFU | NARA |
|---|---|---|
| Relative Strength Index (RSI) | 50.16 | 19.57 |
| Support Level | $11.97 | N/A |
| Resistance Level | $14.64 | $10.59 |
| Average True Range (ATR) | 0.72 | 0.21 |
| MACD | -0.02 | -0.04 |
| Stochastic Oscillator | 57.26 | 25.84 |
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.